Clinical Trial Update: Efficacy and Tolerability of Erenumab in the Prophylactic Treatment of Persistent Post-Traumatic Headache [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating erenumab for prophylaxis of persistent post-traumatic headache shows results on efficacy and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-concussion Syndrome
• Post-traumatic Headache
• Traumatic Brain Injury

Drugs mentioned

• erenumab (erenumab)

Snippet

Sponsor: Danish Headache Center | Conditions: Post-Traumatic Headache, Mild Traumatic Brain Injury | Phase 2 | Status: COMPLETED